 | ||||||
| Ebola | ||||||
| NEWS | ||||||
| Quinn Opportunity Partners Has Decreased Office Depot (ODP) Holding By $320324; Novavax ... It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates. Since January 1, 0001, it had 1 buying transaction, and 0 sales for $11,250 ...
| ||||||
| Maplelane Capital Has Raised Simon Ppty Group New (Put) (SPG) Holding; Shorts at ... It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; anti-viral eye drops against external eye viral infections; and other research programs against Rabies virus, Ebola, and Marburg viruses. Investors sentiment decreased to 1.22 in 2017 Q3.
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar